These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. New Developments in Gastric Neuroendocrine Neoplasms. Exarchou K; Stephens NA; Moore AR; Howes NR; Pritchard DM Curr Oncol Rep; 2022 Jan; 24(1):77-88. PubMed ID: 35059996 [TBL] [Abstract][Full Text] [Related]
26. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors. Karakuş E; Helvacı A; Ekinci O; Dursun A Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ; Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116 [TBL] [Abstract][Full Text] [Related]
28. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Delle Fave G; O'Toole D; Sundin A; Taal B; Ferolla P; Ramage JK; Ferone D; Ito T; Weber W; Zheng-Pei Z; De Herder WW; Pascher A; Ruszniewski P; Neuroendocrinology; 2016; 103(2):119-24. PubMed ID: 26784901 [No Abstract] [Full Text] [Related]
29. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis. Xu TM; Wang CS; Jia CW; Qian JM; Li JN J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897 [TBL] [Abstract][Full Text] [Related]
30. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas. Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A; Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334 [No Abstract] [Full Text] [Related]
31. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature. Neychev V; Kebebew E Int J Surg Oncol; 2017; 2017():6424812. PubMed ID: 28593056 [TBL] [Abstract][Full Text] [Related]
32. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum]. Shimizu N; Kaminishi M Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318 [TBL] [Abstract][Full Text] [Related]
33. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases]. Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793 [TBL] [Abstract][Full Text] [Related]
34. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454 [No Abstract] [Full Text] [Related]
35. [A clinico-pathological study of neuroendocrine tumors in stomach]. Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
37. [Contemporary management of neuroendocrine neoplasms of the female genital organs]. Kuc-Rajca M; Dańska-Bidzińska A Ginekol Pol; 2011 Sep; 82(9):685-9. PubMed ID: 22379929 [TBL] [Abstract][Full Text] [Related]